Predictive factors of achieving therapeutic goals of hypertriglyceridemia

Current Medical Research and Opinion

Volumn 30, Issue 1, 2014, Pages 19-26

  Pinto X ^a   Valdivielso, P ^b   Perez De Juan, J M ^c   Plana, N ^d   Garcia Arias, C ^e   Fuentes, F J ^f   Hernandez Mijares A ^g   Mostaza, J M ^h  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^c Cardiology Department   (Spain)

^d HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

^e Hospital Clinico   (Spain)

^f HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^g HOSPITAL UNIVERSITARIO DR PESET   (Spain)

^h HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Hypertriglyceridemia; Lifestyle; Lipid clinics; Lipid lowering drugs; Predictive factors; Therapeutic goal achievement

Indexed keywords

ANTILIPEMIC AGENT; DIURETIC AGENT; FIBRIC ACID DERIVATIVE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; OMEGA 3 FATTY ACID; ORAL ANTIDIABETIC AGENT; TRIACYLGLYCEROL;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; DIET; DISEASE CONTROL; DISEASE SEVERITY; DYSLIPIDEMIA; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; METABOLIC SYNDROME X; MONOTHERAPY; MULTICENTER STUDY; OBSERVATIONAL STUDY; PREDICTIVE VALUE; PROSPECTIVE STUDY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SMOKING; TREATMENT FAILURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ALCOHOL DRINKING; BLOOD GLUCOSE; BODY MASS INDEX; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERTRIGLYCERIDEMIA; LIFE STYLE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; TRIGLYCERIDES;

EID: 84890487475     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2013.850069     Document Type: Article

References (31)

1. Meseguer CM, Galá n I, Herruzo R, Rodríguez-Artalejo F. Trends in leisure time and occupational physical activity in the Madrid region, 1995-2008. Rev Esp Cardiol 2011;64:21-7
2. Salas-Salvadó J, Ferná ndez-Ballart J, Ros E, et al.; PREDIMED Study Investigators. Effect of a Mediterranean diet supplemented with nuts on metabolic syndrome status: One-year results of the PREDIMED randomized trial. Arch Intern Med 2008;168:2449-58
3. Pintó X, Millá n J, Muñoz A, et al. A very high prevalence of low HDL cholesterol in Spanish patients with acute coronary syndromes. Clin Cardiol 2010;33:418-23
4. Lahoz C, Mostaza JM, Tranche S, et al. Atherogenic dyslipidemia in patients with established coronary artery disease. Nutr Metab Cardiovasc Dis 2012;22:103-8
5. Villar F, Banegas JR, Donado JM, Rodri'guez-Artalejo F. Las enfermedades cardiovasculares y sus factores de riesgo en España: Hechos y cifras. Informe SEA 2007. Madrid: Sociedad Española de Arteriosclerosis, 2007
6. Kotseva K, Wood D, De Backer G, et al.; EUROASPIRE Study Group. EUROASPIRE III: A survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. Eur J Cardiovasc Prev Rehabil 2009;16:121-37
7. Catapano AL, Reiner Z, De Backer G, et al.; European Society of Cardiology (ESC); European Atherosclerosis Society (EAS). ESC/EAS guidelines for the management of dyslipidaemias. The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Atherosclerosis 2011;217:3-46
8. Kotseva K, Stagmo M, De Bacquer D, et al.; EUROASPIRE II Study Group. Treatment potential for cholesterol management in patients with coronary heart disease in 15 European countries: Findings from the EUROASPIRE II survey. Atherosclerosis 2008;197:710-17
9. Jolly K, Bradley F, Sharp S, et al. Randomised controlled trial of follow up care in general practice of patients with myocardial infarction and angina: Final results of the Southampton heart integrated care project (SHIP). The SHIP Collaborative Group. BMJ 1999;318:706-11
10. Mostaza JM, Pintó X, Valdivielso P, et al. Registro de hipertrigliceridemias de la Sociedad Española de Arteriosclerosis. Clínica e Investigación en Arteriosclerosis 2007;19:303-7
11. Valdivielso P, Pintó X, Mateo-Gallego R, et al. Clinical features of patients with hypertriglyceridemia referred to lipid units: Registry of hypertriglyceridemia of the Spanish Arteriosclerosis Society. Med Clin (Barc) 2011;136:231-8
12. Merino J, Mateo-Gallego R, Plana N, et al. Low-fat dairy products consumption is associated with lower triglyceride concentrations in a Spanish hypertriglyceridemic cohort. Nutr Hosp 2013;28:927-33
13. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97
14. Yuan G, Al-Shali KZ, Hegele RA. Hypertriglyceridemia: Its etiology, effects and treatment. CMAJ 2007;176:1113-20
15. Executive Summary: Standards of Medical Care in Diabetes-2013. Diabetes Care 2013;36(Suppl 1):S1-10
16. Perk J, De Backer G, Gohlke H, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Atherosclerosis 2013;223:1-68
17. Karalis DG, Subramanya RD, Hessen SE, et al. Achieving optimal lipid goals in patients with coronary artery disease. Am J Cardiol 2011;107:886-90
18. Pintó X, Meco JF, Corbella E, et al. Secondary preventive program of atherosclerosis in a university hospital. Results and predictors of clinical course. Med Clin (Barc) 2003;120:768-72
19. Van de Wiel A. The effect of alcohol on postprandial and fasting triglycerides. Int J Vasc Med 2012;2012:862504. doi: 10.1155/2012/862504. http:// dx.doi.org/10.1155/2012/862504
20. Putzer G, Roetzheim R, Ramirez AM, et al. Compliance with recommendations for lipid management among patients with type 2 diabetes in an academic family practice. J Am Board Fam Pract 2004;17:101-7
21. Davidson MA. Review of the current status of the management of mixed dyslipidemia associated with diabetes mellitus and metabolic syndrome. Am J Cardiol 2008;102(Suppl):19-27L
22. Ascaso J, Gonzalez Santos P, Hernandez Mijares A, et al. Management of dyslipidemia in the metabolic syndrome: Recommendations of the Spanish HDL-Forum. Am J Cardiovasc Drugs 2007;7:39-58
23. Sadovsky R, Kris-Etherton P. Prescription of omega-3 acid ethyl esters for the treatment of very high triglycerides. Postgrad Med 2009;121:145-53
24. Klop B, Wouter Jukema J, Rabelink TJ, et al. A physician's guide for the management of hypertriglyceridemia: The etiology of hypertriglyceridemia determines treatment strategy. Panminerva Med 2012;54:91-103
25. Chapman MJ, Ginsberg HN, Amarenco P, et al.; European Atherosclerosis Society Consensus Panel. Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: Evidence and guidance for management. Eur Heart J 2011;32:1345-61
26. Sousa MO, Alía P, Pintó X, et al. Interaction between APOA5-1131T4C and APOE polymorphisms and their association with severe hypertriglyceridemia. Clin Chim Acta 2008;395:68-71
27. Ariza MJ, Sá nchez-Chaparro MA, Baró n FJ, et al. Additive effects of LPL, APOA5 and APOE variant combinations on triglyceride levels and hypertriglyceridemia: Results of the ICARIA genetic sub-study. BMC Med Genet 2010;11:66
28. Loveman E, Frampton GK, Shepherd J, et al. The clinical effectiveness and cost-effectiveness of long-Term weight management schemes for adults: A systematic review. Health Technol Assess 2011;15:1-182
29. Valdivielso P, Sá nchez-Chaparro MA, Calvo-Bonacho E, et al.; ICARIA (Ibermutuamur CArdiovascular RIsk Assesment) study group. Association of moderate and severe hypertriglyceridemia with obesity, diabetes mellitus and vascular disease in the Spanish working population: Results of the ICARIA study. Atherosclerosis 2009;207:573-8
30. Julve J, Escolà-Gil JC, Rotllan N, et al. Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome. Arterioscler Thromb Vasc Biol 2010;30:232-8
31. Parks JS, Chung S, Shelness GS. Hepatic ABC transporters and triglyceride metabolism. Curr Opin Lipidol 2012;23:196-200